English
Investor relations
Performance report Investor services
Investor relations

Browse news about PrimeGene to discover valuable information

Performance report
Beijing PrimeGene Science and Technology Co., Ltd. 2022

PrimeGene always sticks to the mission of “benefit patients, pray for health”, constantly enhances the construction of its capability of independent innovation and development, and is striving to become a domestically leading and globally competitive innovative pharmaceutical company and help people stay healthy.

Investor services

Floor 5&6, Tower B, Chongxin Building, Hangfeng Road 13#, Fengtai District, Beijing

Address

010-83141848

Investor hotline

IR@primegene.net

Investor email